SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-105156
Filing Date
2021-04-02
Accepted
2021-04-02 16:13:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d119060d424b5.htm 424B5 398855
2 GRAPHIC g119060g65q08.jpg GRAPHIC 30113
  Complete submission text file 0001193125-21-105156.txt   438339
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251161 | Film No.: 21802105
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences